09:36 AM EST - Avant Technologies Inc : Announced it will create a new company to house either a joint venture, partnership, or acquisition as it further expands its interests in diabetes. In late 2024, Avant entered into a joint venture and licensing agreement with Ainnova Tech, Inc., when the two companies formed Ai-nova Acquisition Corp to advance and commercialize Ainnova's technology portfolio, including its Vision AI platform and its versatile retinal cameras. Avant Technologies Inc
shares O.AVAI are trading unchanged at $0.58.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=AVAI&qmodStoryID=8368341234318225
